Treatment Registry

Company

DoctorAdam

DoctorAdam publishes oral semaglutide, compounded semaglutide and compounded tirzepatide, from $129 to $229 a month.

  • 5 programs
  • 3 molecules
  • 10 readings

Read from doctoradam.com on September 3, 2026. This page records what the company publishes. It is not a review and takes no position on the company.

Go to DoctorAdam

Visit DoctorAdam

We earn nothing from this link. DoctorAdam has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

What it costs

Oral semaglutideOral tablet$129

first month, including the required fees on record · Semaglutide Oral Tablets, from-price

first month, including the required fees on record · Semaglutide Injection, from-price

first month, including the required fees on record · Semaglutide Drop, from-price

Compounded tirzepatideOral tablet$199

first month, including the required fees on record · Tirzepatide Oral Tablets, from-price

first month, including the required fees on record · Tirzepatide Injection, from-price

Terms

PharmacyOlympia Pharmaceuticals, Orlando FL; Carie Boyd Pharmaceuticals, Irving TX
MembershipNot disclosed
States44 states — Alabama, Arizona, Arkansas, California, and 40 more

Not yet checked: consultation fee.

Terms can differ between this company’s programs; each entry carries its own.

Programs

EntryProviderFormPer month
at its shortest term
Link
TR-0491DoctorAdamOral tablet$129
Semaglutide Oral Tablets, from-price
Record
TR-0493DoctorAdam$129
Semaglutide Injection, from-price
Record
TR-0495DoctorAdamSublingual$129
Semaglutide Drop, from-price
Record
TR-0492DoctorAdamOral tablet$199
Tirzepatide Oral Tablets, from-price
Record
TR-0494DoctorAdam$229
Tirzepatide Injection, from-price
Record

Notes

Recorded against this company rather than one program.

September 2, 2026

  1. 1. Same FAQ page contains two contradictory state-coverage claims: one sentence says 'serving patients in 47 states and Washington, D.C., excluding NJ, MS, and AK,' while a separate, explicitly-enumerated 'We proudly serve the following states' list two lines later names only 44 states (also missing MA, RI, and VT). Recorded the explicit enumerated list per the register's rule to prefer a real list over a vague count, and flagged the contradiction here rather than reconciling it. No 'oral tirzepatide' category exists in this register's schema, so the Tirzepatide Oral Tablets product was recorded as compounded tirzepatide / oral-tablet. Cancellation was recorded as not found because the only relevant policy language found describes non-cancellable, non-refundable shipped orders, with no statement that an ongoing subscription itself can be canceled going forward.

Before you act

Cite this

Treatment Registry. (2026). DoctorAdam: recorded programs and prices. Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/doctoradam